55 related articles for article (PubMed ID: 9232936)
1. Pepsinogens I and II in gastric cancer: an immunohistochemical study using monoclonal antibodies.
Huang SC; Miki K; Sano J; Ichinose M; Kawamura N; Oka H; Hirano K; Furihata C; Masugi Y; Takahashi K
Jpn J Cancer Res; 1988 Oct; 79(10):1139-46. PubMed ID: 3143702
[TBL] [Abstract][Full Text] [Related]
2. Gastric cancer among the Japanese in Hawaii.
Nomura AM; Stemmermann GN; Chyou PH
Jpn J Cancer Res; 1995 Oct; 86(10):916-23. PubMed ID: 7493909
[TBL] [Abstract][Full Text] [Related]
3. Does high gastric cancer risk associated with low serum ferritin level reflect achlorhydria? An examination via cross-sectional study.
Kabuto M; Imai H; Tsugane S; Watanabe S
Jpn J Cancer Res; 1993 Aug; 84(8):844-51. PubMed ID: 8407548
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Serum Pepsinogens with and without Co-Testing with Gastrin-17 in Gastric Cancer Risk Assessment-Results from the GISTAR Pilot Study.
Robles C; Rudzite D; Polaka I; Sjomina O; Tzivian L; Kikuste I; Tolmanis I; Vanags A; Isajevs S; Liepniece-Karele I; Razuka-Ebela D; Parshutin S; Murillo R; Herrero R; Young Park J; Leja M
Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885649
[TBL] [Abstract][Full Text] [Related]
5. Enhancing gastric cancer early detection: A multi-verse optimized feature selection model with crossover-information feedback.
Lin J; Zhu F; Dong X; Li R; Liu J; Xia J
Comput Biol Med; 2024 Jun; 175():108535. PubMed ID: 38714049
[TBL] [Abstract][Full Text] [Related]
6. Current status of early gastric cancer screening research.
Hu C; Yuan L; Cheng X
Cancer Biol Med; 2024 Jan; 21(3):218-22. PubMed ID: 38172526
[No Abstract] [Full Text] [Related]
7. The Serum Pepsinogen Test as a Predictor of Kazakh Gastric Cancer.
Juan Cai W; Yin L; Kang Q; Chen Zeng Z; Liang Wang S; Cheng J
Sci Rep; 2017 Mar; 7():43536. PubMed ID: 28251999
[TBL] [Abstract][Full Text] [Related]
8. Serum trefoil factor 3 is a promising non-invasive biomarker for gastric cancer screening: a monocentric cohort study in China.
Huang Z; Zhang X; Lu H; Wu L; Wang D; Zhang Q; Ding H
BMC Gastroenterol; 2014 Apr; 14():74. PubMed ID: 24720760
[TBL] [Abstract][Full Text] [Related]
9. Novel risk markers for gastric cancer screening: Present status and future prospects.
Enomoto S; Maekita T; Ohata H; Yanaoka K; Oka M; Ichinose M
World J Gastrointest Endosc; 2010 Dec; 2(12):381-7. PubMed ID: 21191511
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous detection of different serum pepsinogens and its primary application.
Zhang J; Guo JZ; Xiao HL; Zhu L; Liu HY; Zhang Y; Huang B
World J Gastroenterol; 2010 Jun; 16(24):3072-7. PubMed ID: 20572312
[TBL] [Abstract][Full Text] [Related]
11. Validation of the pepsinogen test method for gastric cancer screening using a follow-up study.
Mizuno S; Kobayashi M; Tomita S; Miki I; Masuda A; Onoyama M; Habu Y; Inokuchi H; Watanabe Y
Gastric Cancer; 2009; 12(3):158-63. PubMed ID: 19890696
[TBL] [Abstract][Full Text] [Related]
12. Reduction in serum pepsinogen I after Roux-en-Y gastric bypass.
Sundbom M; Mårdh E; Mårdh S; Ohrvall M; Gustavsson S
J Gastrointest Surg; 2003; 7(4):529-35. PubMed ID: 12763411
[TBL] [Abstract][Full Text] [Related]
13. Using serum pepsinogens wisely in a clinical practice.
Miki K; Urita Y
J Dig Dis; 2007 Feb; 8(1):8-14. PubMed ID: 17261129
[TBL] [Abstract][Full Text] [Related]
14. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects.
Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Kitadai Y; Komoto K; Tanaka S; Kajiyama G
Am J Gastroenterol; 1998 Jul; 93(7):1090-6. PubMed ID: 9672336
[TBL] [Abstract][Full Text] [Related]
15. [Pepsinogen].
Miki K
Nihon Rinsho; 1995 May; 53(5):1198-202. PubMed ID: 7602778
[TBL] [Abstract][Full Text] [Related]
16. Validity of serum pepsinogen levels and quininium resin test combined for gastric cancer screening.
Kim JR; Lee K; Jung WT; Lee OJ; Kim TH; Kim HJ; Lee JS; Passaro DJ
Cancer Detect Prev; 2005; 29(6):570-5. PubMed ID: 16289505
[TBL] [Abstract][Full Text] [Related]
17. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
18. The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography.
Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Tanaka S; Kajiyama G; Shigenobu T
Hiroshima J Med Sci; 1997 Jun; 46(2):81-6. PubMed ID: 9232936
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
